<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">zdor</journal-id><journal-title-group><journal-title xml:lang="ru">Проблемы здоровья и экологии</journal-title><trans-title-group xml:lang="en"><trans-title>Health and Ecology Issues</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2220-0967</issn><issn pub-type="epub">2708-6011</issn><publisher><publisher-name>Gomel State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.51523/2708-6011.2021-18-3-17</article-id><article-id custom-type="elpub" pub-id-type="custom">zdor-2043</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>СЛУЧАЙ ИЗ КЛИНИЧЕСКОЙ ПРАКТИКИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL CASES</subject></subj-group></article-categories><title-group><article-title>Ограниченная склеродермия: сонографический паттерн в стадию эритемы/отека</article-title><trans-title-group xml:lang="en"><trans-title>Limited scleroderma: sonographic pattern in the stage of erythema/edema</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0808-183X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Юрковский</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Yurkovskiy</surname><given-names>A. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Юрковский Алексей Михайлович, к.м.н., заведующий кафедрой лучевой диагностики, лучевой терапии с курсом ФПК и П </p><p>Гомель</p></bio><bio xml:lang="en"><p>Yurkovskiy A.M., PhD (Med), Head of the Department of Radiation Diagnostics, Radiation Therapy with the course of the Faculty of Professional Development and Retraining </p><p>Gomel</p><p> </p></bio><email xlink:type="simple">yurkovsky@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1897-3575</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Порошина</surname><given-names>Л. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Pаroshуna</surname><given-names>L. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Порошина Лариса Александровна, старший преподаватель кафедры внутренних болезней № 2 с курсом ФПК и П </p><p>Гомель</p></bio><bio xml:lang="en"><p>Paroshyna L.A., Senior Lecturer at Department of Internal Diseases No.2 with the course of the Faculty of Professional Development and Retraining </p><p>Gomel</p></bio><email xlink:type="simple">plary@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0977-5481</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ачинович</surname><given-names>С. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Achinovich</surname><given-names>S. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ачинович Сергей Леонидович, к.м.н., заведующий патологоанатомическим отделением </p><p>Гомель</p></bio><bio xml:lang="en"><p>Achinovich S.L., PhD (Med), Head of the Pathoanatomical Department </p><p>Gomel</p></bio><email xlink:type="simple">ser.achinowitch2017@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Гомельский государственный медицинский университет</institution></aff><aff xml:lang="en"><institution>Gomel State Medical University</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Гомельский областной клинический онкологический диспансер»</institution></aff><aff xml:lang="en"><institution>Gomel Regional Clinical Oncological Dispensary</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>01</day><month>10</month><year>2021</year></pub-date><volume>18</volume><issue>3</issue><fpage>137</fpage><lpage>143</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Юрковский А.М., Порошина Л.А., Ачинович С.Л., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Юрковский А.М., Порошина Л.А., Ачинович С.Л.</copyright-holder><copyright-holder xml:lang="en">Yurkovskiy A.M., Pаroshуna L.A., Achinovich S.L.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.gsmu.by/jour/article/view/2043">https://journal.gsmu.by/jour/article/view/2043</self-uri><abstract><sec><title>Цель исследования</title><p>Цель исследования. Дать описание сонопаттерна ограниченной склеродермии (ОС) в ранние сроки от момента появления эритемы.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Описан клинический случай заболевания ограниченной бляшечной склеродермией. Сонографическое исследование проводилось на ультразвуковом сканере с применением датчика с рабочими частотами 10–16–18 МГц. Забор материала для гистологического исследования кожи осуществлялся под сонографическим контролем из участка с наиболее выраженными воспалительными изменениями.</p></sec><sec><title>Результаты</title><p>Результаты. Установлено, что повышение эхогенности дермы, «размытость» границы дерма/гиподерма, повышенная эхогенность и «сталактитоподобный» паттерн подкожно-жировой клетчатки имеют место в первую неделю заболевания; нормализация или существенное улучшение сонопаттерна отмечается к концу 2-й, началу 3-й недели от момента появления эритемы.</p></sec><sec><title>Заключение</title><p>Заключение. Между гистологическим и сонографическим паттерном имеется определенный параллелизм, что позволяет адекватно оценивать и активность, и стадию процесса при ОС.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective. To describe the sonopattern of limited scleroderma (LS) in the early stages after the onset of erythema.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The work describes a clinical case of limited plaque scleroderma. The sonographic examination was carried out on an ultrasound scanner using a transducer with operating frequencies of 10–16–18 MHz. Material sampling for the histologic examination of the skin was performed from the area with the most pronounced inﬂammatory changes under sonographic control.</p></sec><sec><title>Results</title><p>Results. It has been found that increased echogenicity of the dermis, “blurring” of the dermis/hypodermis boundary, increased echogenicity and the “stalactite-like” pattern of subcutaneous fat occur in the frst week of the disease; normalization or a signifcant improvement of the sonopattern is noted by the end of the second week or by the beginning of the third week after the onset of erythema.</p></sec><sec><title>Conclusion</title><p>Conclusion. There is a certain parallelism between the histologic and sonographic patterns, which makes it possible to adequately assess both the activity and the stage of the LS process.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>ограниченная склеродермия</kwd><kwd>сонография</kwd><kwd>гистопатологические изменения</kwd></kwd-group><kwd-group xml:lang="en"><kwd>limited scleroderma</kwd><kwd>sonography</kwd><kwd>histopathologic changes</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Панкратов ОВ, Порошина ЛА. Ограниченная склеродермия: этиопатогенез, клиника, диагностика, лечение. Здравоохранение. 2019;(6):28-38.</mixed-citation><mixed-citation xml:lang="en">Pankratov OV, Paroshyna LA. Localized scleroderma: etiopathogenesis, clinical presentation, diagnosis, treatment. Healthcape. 2019;(6):28-38. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Бакалец НФ, Порошина ЛА. Метаболический синдром как фактор риска кожной патологии. Проблемы здоровья и экологии. 2018;(4):9-15. [дата обращения 2021 май 18]. Режим доступа: https://journal.gsmu.by/jour/article/view/67</mixed-citation><mixed-citation xml:lang="en">Bakalets NF, Poroshina LA. Metabolic syndrome as a risk factor for skin pathology. Health and Ecology Issues. 2018;(4):9-15. [date of access 2021 Маy 18]. Available from: https://journal.gsmu.by/jour/article/view/67 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Юрковский АМ. Порошина ЛА, Ачинович СЛ. Диагностическое значение степени экспрессии биомаркеров Collagen IV, CD 34 и Vimentin у пациентов с ограниченной склеродермией. Здравоохранение. 2021;(3):56-60.</mixed-citation><mixed-citation xml:lang="en">Yurkovskiy AM, Poroshina LA, Achinovich SL. Diagnostic value of the degree of expression of biomarkers Collagen IV, CD 34 and Vimentin in patients with limited scleroderma. Healthcape. 2021;(3):56-60. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Lis-Święty A, Janicka I, Skrzypek-Salamon A, Brzezińska-Wcisło L. A systematic review of tools for determining activity of localized scleroderma in paediatric and adult patients. J Eur Acad Dermatol Venereol. 2017;31(1):30-37. DOI: https://doi.org/10.1111/jdv.13790</mixed-citation><mixed-citation xml:lang="en">Lis-Święty A, Janicka I, Skrzypek-Salamon A, Brzezińska-Wcisło L. A systematic review of tools for determining activity of localized scleroderma in paediatric and adult patients. J Eur Acad Dermatol Venereol. 2017;31(1):30-37. DOI: https://doi.org/10.1111/jdv.13790</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Nezafati KA, Cayce RL, Susa JS, Setiawan AT, Tirkes T, Bendeck SE, Heidi T Jacobe HT. 14-MHz ultrasonography as an outcome measure in morphea (localized scleroderma). Arch Dermatol. 2011;147(9):1112-1115. DOI: https://doi.org/10.1001/archdermatol.2011.243</mixed-citation><mixed-citation xml:lang="en">Nezafati KA, Cayce RL, Susa JS, Setiawan AT, Tirkes T, Bendeck SE, Heidi T Jacobe HT. 14-MHz ultrasonography as an outcome measure in morphea (localized scleroderma). Arch Dermatol. 2011;147(9):1112-1115. DOI: https://doi.org/10.1001/archdermatol.2011.243</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Nouri S, Jacobe H. Recent developments in diagnosis and assessment of morphea. Curr Rheumatol Rep. 2013;15(2):308. DOI: https://doi.org/10.1007/s11926-012-0308-9</mixed-citation><mixed-citation xml:lang="en">Nouri S, Jacobe H. Recent developments in diagnosis and assessment of morphea. Curr Rheumatol Rep. 2013;15(2):308. DOI: https://doi.org/10.1007/s11926-012-0308-9</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Wortsman X, Wortsman J, Sazunic I, Carreño L. Activity assessment in morphea using color Doppler ultrasound. J Am Acad Dermatol. 2011;65(5):942-948. DOI: https://doi.org/10.1016/j.jaad.2010.08.027</mixed-citation><mixed-citation xml:lang="en">Wortsman X, Wortsman J, Sazunic I, Carreño L. Activity assessment in morphea using color Doppler ultrasound. J Am Acad Dermatol. 2011;65(5):942-948. DOI: https://doi.org/10.1016/j.jaad.2010.08.027</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Cosnes A, Anglade MC, Revuz J, Radier C. Thirteen-megahertz ultrasound probe: its role in diagnosing localized scleroderma. Br J Dermatol. 2003 Apr;148(4):724-729. DOI: https://doi.org/10.1046/j.1365-2133.2003.05289.x</mixed-citation><mixed-citation xml:lang="en">Cosnes A, Anglade MC, Revuz J, Radier C. Thirteen-megahertz ultrasound probe: its role in diagnosing localized scleroderma. Br J Dermatol. 2003 Apr;148(4):724-729. DOI: https://doi.org/10.1046/j.1365-2133.2003.05289.x</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Porta F, Kaloudi O, Garzitto А, Prignano F, Nacci F, Falcini F, Cerinic MM. High frequency ultrasound can detect improvement of lesions in juvenile localized scleroderma. Mod Rheumatol. 2014;24(5):869-873. DOI: https://doi.org/10.3109/14397595.2013.844301</mixed-citation><mixed-citation xml:lang="en">Porta F, Kaloudi O, Garzitto А, Prignano F, Nacci F, Falcini F, Cerinic MM. High frequency ultrasound can detect improvement of lesions in juvenile localized scleroderma. Mod Rheumatol. 2014;24(5):869-873. DOI: https://doi.org/10.3109/14397595.2013.844301</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Li SC, Liebling MS, Ramji FG, Opitz S, Mohanta A, Kornyat T, Zhang S, et al. Sonographic evaluation of pediatric localized scleroderma: preliminary disease assessment measures. Pediatric Rheumatology. 2010 Apr 27;8:14. DOI: http://www.ped-rheum.com/content/8/1/14</mixed-citation><mixed-citation xml:lang="en">Li SC, Liebling MS, Ramji FG, Opitz S, Mohanta A, Kornyat T, Zhang S, et al. Sonographic evaluation of pediatric localized scleroderma: preliminary disease assessment measures. Pediatric Rheumatology. 2010 Apr 27;8:14. DOI: http://www.ped-rheum.com/content/8/1/14</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Eisenbeiss C, Welzel J, Eichler W, Klotz K. Inﬂuence of body water distribution on skin thickness: measurements using high-frequency ultrasound. Br J Dermatol. 2001;144(5):947-951. DOI: https://doi.org/10.1046/j.1365-2133.1998.02410.x</mixed-citation><mixed-citation xml:lang="en">Eisenbeiss C, Welzel J, Eichler W, Klotz K. Inﬂuence of body water distribution on skin thickness: measurements using high-frequency ultrasound. Br J Dermatol. 2001;144(5):947-951. DOI: https://doi.org/10.1046/j.1365-2133.1998.02410.x</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
